Investigating the Preventative Ability of Massage Therapy on Paclitaxel Induced Peripheral Neuropathy

Bryan Schneider5 enrolled

Overview

Feasibility study to examine the preventative ability of massage therapy on paclitaxel induced peripheral neuropathy in breast cancer

Study Type

INTERVENTIONAL

Allocation

Purpose

SUPPORTIVE_CARE

Masking

NONE

Enrollment

Conditions

Breast Cancer Neuropathy Neuropathy;Peripheral

Interventions

MassageOTHER

A 20 minute massage protocol will be administered in a chair by a licensed massage therapist no more than 24 hours prior to each paclitaxel infusion.

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: 1\) Breast cancer diagnosis 2) Planning to receive chemotherapy treatment with paclitaxel in the curative setting (adjuvant or neoadjuvant) on a weekly or bi-weekly schedule Exclusion Criteria: 1)Diabetes or other neurological disorder 2) Current or previous peripheral neuropathy 3)Previous treatment with paclitaxel 4)Active deep vein thrombosis (DVT) within last 12 months or history of untreated lower extremity DVT

Locations (1)

Indiana University Melvin & Bren Simon Cancer Center

Indianapolis, Indiana, United States

Outcomes

Primary Outcomes

Feasibility of Recruitment

rate of enrollment

Time frame: 1 year

Feasibility of Retention

rate of drop out or consent withdraw

Time frame: 1 year

Secondary Outcomes

Incidence of paclitaxel induced peripheral neuropathy

incidence of paclitaxel induced peripheral neuropathy as measured using the Assessment of Cancer Therapy-Neurotoxicity (FACT-Ntx) questionaire

Time frame: 10 months

Severity of paclitaxel induced peripheral neuropathy

severity of paclitaxel induced peripheral neuropathy measured by Assessment of Cancer Therapy-Neurotoxicity (FACT-Ntx) questionnaire

Time frame: 10 months

Rate of pharmacological interventions

pharmacological interventions for paclitaxel induced peripheral neuropathy

Time frame: 10 months

Paclitaxel dose modification

rate of dose modifications to paclitaxel treatment

Time frame: 4 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.